| Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225 F Ciardiello, R Bianco, V Damiano, S De Lorenzo, S Pepe, S De Placido, ... Clinical Cancer Research 5 (4), 909-916, 1999 | 436 | 1999 |
| The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases MP Cosma, S Pepe, I Annunziata, RF Newbold, M Grompe, G Parenti, ... Cell 113 (4), 445-456, 2003 | 406 | 2003 |
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, ... British journal of cancer 92 (9), 1644-1649, 2005 | 355 | 2005 |
| Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) C Bianco, G Tortora, R Bianco, R Caputo, BM Veneziani, R Caputo, ... Clinical cancer research 8 (10), 3250-3258, 2002 | 338 | 2002 |
| BRAF is a therapeutic target in aggressive thyroid carcinoma G Salvatore, V De Falco, P Salerno, TC Nappi, S Pepe, G Troncone, ... Clinical Cancer Research 12 (5), 1623-1629, 2006 | 213 | 2006 |
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer GDV Scarpati, F Falcetta, C Carlomagno, P Ubezio, S Marchini, ... International journal of radiation oncology* biology* physics 83 (4), 1113-1119, 2012 | 193 | 2012 |
| p53 Alterations in Non-Small Cell Lung Cancers Correlate with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes A Marchetti, F Buttitta, G Merlo, F Diella, S Pellegrini, S Pepe, ... Cancer research 53 (12), 2846-2851, 1993 | 192 | 1993 |
| cAMP-dependent protein kinase: role in normal and malignant growth YS Cho-Chung, S Pepe, T Clair, ADO Budillon, M Nesterova Critical reviews in oncology/hematology 21 (1-3), 33-61, 1995 | 190 | 1995 |
| Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in … E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ... Journal of cellular physiology 195 (1), 139-150, 2003 | 184 | 2003 |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer S De Placido, M De Laurentiis, C Carlomagno, C Gallo, F Perrone, ... Clinical cancer research 9 (3), 1039-1046, 2003 | 183 | 2003 |
| Periodic activation of Wnt/β-catenin signaling enhances somatic cell reprogramming mediated by cell fusion F Lluis, E Pedone, S Pepe, MP Cosma Cell stem cell 3 (5), 493-507, 2008 | 175 | 2008 |
| Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous … G Fontanini, S Vignati, D Bigini, A Mussi, H Lucchi, CA Angeletti, ... European Journal of Cancer 31 (2), 178-183, 1995 | 167 | 1995 |
| Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors MP Morelli, T Cascone, T Troiani, F De Vita, M Orditura, G Laus, ... Annals of Oncology 16, iv61-iv68, 2005 | 157 | 2005 |
| Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications F Perri, R Pacelli, G Della Vittoria Scarpati, L Cella, M Giuliano, ... Head & neck 37 (5), 763-770, 2015 | 152 | 2015 |
| Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells A Leardi, M Caraglia, C Selleri, S Pepe, C Pizzi, R Notaro, A Fabbrocini, ... British journal of haematology 102 (3), 746-752, 1998 | 138 | 1998 |
| Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. G Tortora, H Yokozaki, S Pepe, T Clair, YS Cho-Chung Proceedings of the National Academy of Sciences 88 (5), 2011-2015, 1991 | 131 | 1991 |
| 209. Correction of Hunter Syndrome in the MPSII Mouse Model by AAV2/8-Mediated Gene Delivery M Cardone, VA Polito, S Pepe, L Mann, A D'azzo, A Auricchio, A Ballabio, ... Molecular Therapy 13, S81, 2006 | 127 | 2006 |
| Ipilimumab in the treatment of metastatic melanoma: management of adverse events G Della Vittoria Scarpati, C Fusciello, F Perri, F Sabbatino, S Ferrone, ... OncoTargets and therapy, 203-209, 2014 | 123 | 2014 |
| The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node‐negative non‐small cell lung cancer G Fontanini, P Macchiarini, S Pepe, A Ruggievo, M Hardin, D Bigini, ... Cancer 70 (6), 1520-1527, 1992 | 122 | 1992 |
| Poly (adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region S Staibano, S Pepe, LL Muzio, P Somma, M Mascolo, G Argenziano, ... Human pathology 36 (7), 724-731, 2005 | 108 | 2005 |
